Clinical study to evaluate the therapeutic safety and efficacy of Habb-e-Mafasil in the management of Waja’al- Rukba (Primary KneeOsteoarthritis): An open label block randomized standard control study. - NI

Central Council for Research In Unani Medicine New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年3月4日

研究概览

暂无简介。

•patients irrespective of gender in the age group of 20 to 65 years will be included. clically and radiologically diagnosed patients with kellegren-lawrence grades 1,2 and 3 and with BMI less than 35 kg per meter square. patients who have agreed to sign the informed consent form and are willing to follow up as per the study protocol.

•1. Kellgren- Lawrence grade 4 knee osteoarthritis.
•2. Pregnant and Lactating women.
•3. BMI more than 35kg per meter square.
•4. History of recent knee infection.
•5. Prior knee surgery.
•6. Prior bone disease such as Osteomyelitis
•7. Prior trauma to the knee joint.
•8. Patients having received intra-articular knee injection as that of corticosteroids or hyaluronic acid or any investigational drug in the past one month.
•9. Known cases of inflammatory joint disease as Rheumatoid Arthritis.
•10. Patients with history of any significant systemic diseases like cardiovascular, gastrointestinal, renal, hepatic.
•11. Patients with uncontrolled diabetes mellitus and hypertension.
•12. Patients who refuse to give the written consent for the study and unwillingness to come for regular follow up as described in the study plan.

发起方

Central Council for Research In Unani Medicine New Delhi